Established in 1986, Hadasit is the Technology Transfer Company of Hadassah Medical Organization (Hadassah) in Jerusalem, Israel.
Our Mission
Hadasit’s mission is to promote and commercialize the vast intellectual property and wealth of pre-clinical and clinical R&D capabilities generated at Hadassah on an ongoing basis through product licensing, establishing start-up companies and collaboration with academy and industry.
Our Achievements
Hadasit has gained global recognition for successfully enterprising biomedical technologies developed at Hadassah. We currently boast a rich portfolio of over 200 patent families covering a wide variety of novel therapeutics, diagnostics and medical devices. Of the more than 30 companies established by Hadasit, eight are currently operating under our publicly-traded subsidiary, Hadasit Bio-Holdings (TASE: HDST). In addition, dozens of research and license & option agreements are in place with global strategic partners.
Our Resources
The Hadassah University Medical Center is a world class medical research institution with a rich history of clinical excellence:
• Two academic hospitals with 1100 beds.
• An annual turnover of 100,000 inpatients and 1,000,000 outpatient visits.
• We are capable of conducting any clinical research project, from the smallest pilot study to multi-center trials.
• A newly established Phase I unit – the Hadassah Clinical Research Center (HCRC).
• Our expertise covers Phase I to Phase IV - More than 240 trials and outcomes research projects were completed in 2009.
• 12 of 20 of the Israel Academy of Sciences & Humanities awards for basic medical research in 2008 awarded to Hadassah researchers.
• 40% of all bio-medical research in Israel is conducted at Hadassah.
• Studies conducted in more than 20 therapeutic areas.
Services to Sponsors
Hadasit, in collaboration with Hadassah University Medical Center, promotes the wealth of pre-clinical research services that the Hadassah Ein Kerem and Mount Scopus campuses have to offer the domestic and international biotechnology, pharmaceutical and medical device industries. Hadasit also handles the contractual aspects of all clinical trials conducted at Hadassah. We are charged with assisting our faculty and sponsors to comply with all regulations and requirements that concern clinical trials. Our mission is to explain, assist, and challenge the conduct of clinical trials while meeting the highest ethical standards and following the applicable federal policies that govern their conduct. All personnel conducting clinical trials have been expertly trained to follow strict GCP guidelines and internal standard operating procedures that govern the investigation of test articles.
Hadassah’s GMP Facility
The HCRC is supported by a full-service GMP facility located on the premises of Hadassah Medical Center. The GMP team can accommodate the protocol requests of any Phase I or Phase II study. In addition, the team can draft GMP protocols for the study sponsor, whose personnel it will also train to participate in the laboratory process.
The Hadassah-Medical Center Hebrew University Biotechnology Park (JBP) is located in the heart of Ein Kerem Hadassah medical campus in Jerusalem. The JBP is a state of the art customized facility, tailored to the needs of biotech companies. Companies will benefit from close proximity to the rich infrastructure and extensive facilities of the Hebrew University schools of medicine, dentistry, pharmacy, nursing and public health, and the Hadassah University Hospital.
This nearness fosters synergistic partnership and meets the needs of early stage companies, large companies, multi-national life science companies, growing firms, and the related institutional research facilities, all who share the goal of developing therapeutic life science technologies. JBP will serve as a catalyst to transform Jerusalem from a scientific research hub to an economic engine for bioscience technologies.
